WGS
WGS
GeneDx Holdings Corp.Company Information
Recommendation Details
Midcap holds up to 5 names drawn from Mid caps above $2B, most volatile third by model volatility score. The most volatile third of the mid-cap band on a 6 to 8 day window. Positions are held for 6-8 days, each position carries a 25% stop-loss. Benchmark: S&P MidCap 400.
Company Description
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.